Web Results

Nilotinib

en.wikipedia.org/wiki/Nilotinib

Nilotinib (AMN107, trade name Tasigna), in the form of the hydrochloride monohydrate salt, is a small-molecule tyrosine kinase inhibitor approved for the ...

Nilotinib: MedlinePlus Drug Information - National Library of Medicine

www.nlm.nih.gov/medlineplus/druginfo/meds/a608002.html

Nilotinib may cause QT prolongation (an irregular heart rhythm that can lead to fainting, loss of consciousness, seizures, or sudden death). Tell your doctor if you  ...

Nilotinib - National Cancer Institute

www.cancer.gov/about-cancer/treatment/drugs/nilotinib

This page contains brief information about nilotinib and a collection of links to more information about the use of this drug, research results, and ongoing clinical ...

FDA Approval for Nilotinib - National Cancer Institute

www.cancer.gov/about-cancer/treatment/drugs/fda-nilotinib

Jul 3, 2013 ... Information from the FDA about the approval of nilotinib and the clinical trials that led to the approval.

Nilotinib (Tasigna) | Cancer Research UK

www.cancerresearchuk.org/about-cancer/cancers-in-general/treatment/cancer-drugs/nilotinib

Jan 2, 2015 ... Read about the cancer treatment drug nilotinib, otherwise known as Tasigna, including what it is, how it works and possible side effects.

DrugBank: Nilotinib

www.drugbank.ca/drugs/DB04868

Nilotinib, also known as AMN107, is a tyrosine kinase inhibitor under investigation as a possible treatment for chronic myelogenous leukemia (CML). In June ...

Should Patients and Families Be Considering Tasigna (Nilotinib ...

parkinson.org/our-impact/press-room/press-releases/should-patients-and-families-be-considering-tasigna-nilotinib-therapy-for-parkinsons

Oct 21, 2015 ... The NPF Recommends Further Study but Not Clinical Use of this Investigational Drug. Tasigna (Nilotinib) is a leukemia drug that has recently ...

Nilotinib - Chemotherapy Drugs - Chemocare

chemocare.com/chemotherapy/drug-info/Nilotinib.aspx

(nye-LOE-ti-nib). Generic Name: nilotinib. Trade Name(s): Tasigna. Nilotinib is the generic for the trade chemotherapy drug Tasigna. In some cases, health care  ...

nilotinib, Tasigna: Drug Facts, Side Effects and Dosing - MedicineNet

www.medicinenet.com/nilotinib/article.htm

May 27, 2015 ... Information on the drug nilotinib (Tasigna) prescribed for the treatment of leukemia. Side effects, drug interactions, dosing information, and ...

Tasigna 200 mg hard capsules - Summary of Product Characteristics

www.medicines.org.uk/emc/medicine/20827

May 19, 2016 ... The bioavailability of nilotinib might be reduced in patients with total gastrectomy (see section 5.2). More frequent follow-up of these patients ...

More Info

Tasigna - Home

www.tasigna.com

... of Product Characteristics; Print. TASIGNA (nilotinib) .... TASIGNA<sup>®</sup> (Nilotinib) is approved for use in 110 countries around the world. Healthcare Professionals  ...

Tasigna Capsules (Nilotinib Capsules) Drug Information ...

www.rxlist.com

Nov 30, 2015 ... Learn about the prescription medication Tasigna Capsules (Nilotinib Capsules), drug uses, dosage, side effects, drug interactions, warnings, ...

Tasigna - Novartis

www.pharma.us.novartis.com

See full prescribing information for. TASIGNA. TASIGNA® (nilotinib) Capsules for oral use. Initial U.S. Approval: 2007. WARNING: QT PROLONGATION AND ...